Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Animal Antimicrobial and Antibiotics Market by Product (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins) by Mode of Delivery (Premixes, Oral Powders, Oral Solutions, Injections) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Animal Antimicrobials and Antibiotics Market was valued at USD XX billion in the year 2017. Global Animal Antimicrobials and Antibiotics market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.

In the Global Animal Antimicrobials and Antibiotics Market, by region, North America region holds the highest market share in 2017 and the Asia Pacific is also the market is considered as the fastest growing market in the forecasted period owing to their market demands. At the country level, U.S, China, and India are projected to grow strongly in the coming years.

Drivers:

            Rising Demand for Animal-Derived Food Products

Restraints:

            Changing government regulations and norms.

            Lack of New Antibiotics

Opportunities:

            Investment opportunity in emerging markets

Challenges:

            Strict regulatory framework

The segmentation is done on the basis of resin type, of product, mode of delivery, animal type, and region. On the basis of the product, the market is segmented into tetracyclines, penicillins, macrolides, aminoglycosides, sulfonamides, fluoroquinolones, lincosamides, cephalosporins, and other antimicrobials and antibiotics. The tetracyclines accounted for the largest share of the animal antibiotics and antimicrobials market in 2017.

Zoetis, Inc. (U.S.), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Bayer AG (Germany), Virbac (France), Boehringer Ingelheim GmbH (Germany), Sanofi (France), Ceva Sante Animale (France), Vetoquinol S.A. (France), and Dechra Pharmaceuticals PLC (U.K.) are some of the key players in the Global Animal Antimicrobials and Antibiotics market.

Key Benefits for Stakeholders

Animal Pharmaceutical Manufacturers

Animal Healthcare Product Distributors

Animal Health Research and Development (R&D) Companies

Government Associations

Market Research and Consulting Firms

By Product

Tetracyclines

Penicillins

Sulfonamides

Macrolides

Aminoglycosides

Lincosamides

Fluoroquinolones

Cephalosporins

Other Antimicrobials and Antibiotics

By Mode of Delivery

Premixes

Oral Powders

Oral Solutions

Injections

Other modes of delivery

By Animal Type

Food-Producing Animals

            Cattle

            Pigs

            Poultry

            Sheep and Goats

            Other Food-Producing Animals

Companion Animals

            Dogs

            Cats

            Horses

            Other Companion Animals

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Zoetis, Inc. 

Boehringer Ingelheim GmbH 

Eli Lilly and Company 

Merck & Co., Inc. 

Bayer AG 

Sanofi 

Ceva Sante Animale 

Virbac 

Vetoquinol S.A. 

Dechra Pharmaceuticals PLC

(A brief overview of 10 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Animal Antimicrobials and Antibiotics Market, By Product

6.1 Tetracyclines

6.2 Penicillins

6.3 Sulfonamides

6.4 Macrolides

6.5 Aminoglycosides

6.6 Lincosamides

6.7 Fluoroquinolones

6.8 Cephalosporins

6.9 Other Antimicrobials and Antibiotics

7. Animal Antimicrobials and Antibiotics Market, By Mode of Delivery

7.1 Premixes

7.2 Oral Powders

7.3 Oral Solutions

7.4 Injections

7.5 Other modes of delivery

8. Animal Antimicrobials and Antibiotics Market, By Animal Type

8.1 Food-Producing Animals

            8.1.1 Cattle

            8.1.2 Pigs

            8.1.3 Poultry

            8.1.4 Sheep and Goats

            8.1.5 Other Food-Producing Animals

8.2 Companion Animals

            8.2.1 Dogs

            8.2.2 Cats

            8.2.3 Horses

            8.2.4 Other Companion Animals

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. France

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. South Korea

       9.4.2. China

       9.4.3. Japan

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Zoetis, Inc. 

10.2 Boehringer Ingelheim GmbH 

10.3 Eli Lilly and Company 

10.4 Merck & Co., Inc. 

10.5 Bayer AG 

10.6 Sanofi 

10.7 Ceva Sante Animale 

10.8 Virbac 

10.9 Vetoquinol S.A. 

10.10 Dechra Pharmaceuticals PLC

(A brief overview of 10 companies is also provided.)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports